advertisement
Huang P 15
Showing records 1 to 15 | Display all abstracts from Huang P126101 GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
Amaral DC
American Journal of Ophthalmology 2025; 271: 488-497
126674 Thioredoxin-interacting protein (TXNIP) inhibition promotes retinal ganglion cell survival and facilitates M1-like microglial transformation via the PI3K/Akt pathway in glaucoma
Chen J
Molecular Medicine 2024; 30: 283
126101 GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
Amaral DC; Amaral DC
American Journal of Ophthalmology 2025; 271: 488-497
126674 Thioredoxin-interacting protein (TXNIP) inhibition promotes retinal ganglion cell survival and facilitates M1-like microglial transformation via the PI3K/Akt pathway in glaucoma
Zhong H
Molecular Medicine 2024; 30: 283
126101 GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
Guedes J; Guedes J; Guedes J; Cruz MRB
American Journal of Ophthalmology 2025; 271: 488-497
126674 Thioredoxin-interacting protein (TXNIP) inhibition promotes retinal ganglion cell survival and facilitates M1-like microglial transformation via the PI3K/Akt pathway in glaucoma
Shen B; Yu H
Molecular Medicine 2024; 30: 283
126101 GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
Cheidde L
American Journal of Ophthalmology 2025; 271: 488-497
126674 Thioredoxin-interacting protein (TXNIP) inhibition promotes retinal ganglion cell survival and facilitates M1-like microglial transformation via the PI3K/Akt pathway in glaucoma
Zhang Y
Molecular Medicine 2024; 30: 283
126101 GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
Nepomuceno M; Magalhães PLM
American Journal of Ophthalmology 2025; 271: 488-497
126674 Thioredoxin-interacting protein (TXNIP) inhibition promotes retinal ganglion cell survival and facilitates M1-like microglial transformation via the PI3K/Akt pathway in glaucoma
Han R; Huang P
Molecular Medicine 2024; 30: 283
126101 GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
Brazuna R
American Journal of Ophthalmology 2025; 271: 488-497
126674 Thioredoxin-interacting protein (TXNIP) inhibition promotes retinal ganglion cell survival and facilitates M1-like microglial transformation via the PI3K/Akt pathway in glaucoma
Huang S
Molecular Medicine 2024; 30: 283
126101 GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
Mora-Paez DJ; Mora-Paez DJ; Mora-Paez DJ; Huang P
American Journal of Ophthalmology 2025; 271: 488-497
126674 Thioredoxin-interacting protein (TXNIP) inhibition promotes retinal ganglion cell survival and facilitates M1-like microglial transformation via the PI3K/Akt pathway in glaucoma
Zhong Y
Molecular Medicine 2024; 30: 283
126101 GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
Razeghinejad R; Schuman JS; Myers JS
American Journal of Ophthalmology 2025; 271: 488-497
